Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Menichetti and Giusy Tiseo.
Connection Strength
0.646
-
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern. Infect Dis Ther. 2021 Dec; 10(4):2479-2488.
Score: 0.241
-
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study. Thromb Res. 2021 08; 204:88-94.
Score: 0.059
-
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome. Sci Rep. 2021 03 22; 11(1):6515.
Score: 0.058
-
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021 03 12; 76(4):1078-1084.
Score: 0.058
-
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021 Feb 03; 10(4).
Score: 0.058
-
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
Score: 0.058
-
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa563.
Score: 0.057
-
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care. 2020 10; 43(10):2345-2348.
Score: 0.056